共 50 条
- [33] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial Annals of Surgical Oncology, 2011, 18 : 1575 - 1581
- [34] CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer ANNALS OF ONCOLOGY, 2017, 28
- [35] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial Annals of Surgical Oncology, 2017, 24 : 623 - 623
- [40] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial) ANNALS OF ONCOLOGY, 2019, 30 : 877 - 877